Skip to content
Credit reportVerdict and grounds
Made on 18-11-2026 at 00:15
Reference CK-0474901211-20261118

INFIMEDIC

ActiveNon-profit association0474.901.211Rue du Tuffeau 3, 1357 Hélécine
Nursing and midwifery (NACE 86940) · founded in 2001 · 3 employees on 31-12-2025 · accounts in the micro format

Sources: the KBO register on 18-11-2026; the National Bank, 2025 annual accounts filed on 14-07-2026; the Belgian Official Gazette, latest deed of 08-09-2022.

Credit verdict
Checked score 2025
The score, from 0 to 100, reflects the bankruptcy probability and the standing among sector peers.
Bankruptcy probability within 12 months
The median of 24,213 micro companies in the human health sector (NACE 86) is below 0.1%.
Gross margin
€123,849
▲ 3.3% against 2024
Net result
€6,024
▼ 68.8% against 2024
Equity
€73,343
▲ 8.9% against 2024
Cash
€60,295
▲ 13.4% against 2024

Grounds

the facts the verdict rests on, each with its source
  1. In 2025, INFIMEDIC closed with a net profit of €6,024.Annual accounts 2025 page 2
  2. Equity stands at €73,343, or 95.0% of the balance sheet total of €77,223.Annual accounts 2025 page 2
  3. The 2025 accounts reached the National Bank 17 days before the end of the term.National Bank, filing of 14-07-2026 page 4

Representation

Checked did not find the signing rule in the deeds it read.

Ownership

Accounts in the micro format list no shareholders. Checked found none in the deeds or the LEI register either.

INFIMEDIC · 0474.901.211 · credit report of 18-11-2026Page 1 of 5
INFIMEDIC0474.901.211 · report of 18-11-2026

Financial situation

Annual accounts 2021 to 2025, as filed with the National Bank

Gross margin and net resultin euro

2021170,0062022128,6092023108,5982024119,8832025123,849202128,36920224,6902023-22,756202419,30520256,024
gross marginnet result

Equity and debtsin euro

2021202220232024202573,3433,880
equitydebts

Cashin euro

202139,170202246,103202328,918202453,154202560,295
on the balance sheet date
Financial year20212022202320242025Trend
Results
Gross margin€170,006€128,609€108,598€119,883€123,849
Operating result€28,443€5,570-€21,851€20,008€6,571
Net result€28,369€4,690-€22,756€19,305€6,024
Balance sheet at the closing date
Equity€66,080€70,770€48,014€67,319€73,343
Debts€5,247€5,779€3,105€2,935€3,880
Debts due within one year€5,247€5,779€3,105€2,935€3,880
Cash€39,170€46,103€28,918€53,154€60,295
Balance sheet total€71,327€76,549€51,119€70,254€77,223
Operations
Employees in full-time equivalents3.63.23.43.22.7
Ratios
Solvency92.6%92.5%93.9%95.8%95.0%
Liquidity8.519.049.6720.3415.77

Source: Annual accounts 2025, micro format, filed on 14-07-2026 (2026-00291119); Annual accounts 2024, micro format, filed on 18-07-2025 (2025-00288124); Annual accounts 2021 to 2023, filed from 29-08-2022 to 29-08-2024 (2022-20411033, 2023-00404975, 2024-00398719).

The operating result of 2025 is 67% lower than in 2024.

Debts rose by €945 in 2025, of which €2,350 to suppliers.

The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.

INFIMEDIC states no turnover; the micro format does not require it. The gross margin, what is left after purchases, rose from €119,883 to €123,849.

INFIMEDIC · 0474.901.211 · credit report of 18-11-2026Page 2 of 5
INFIMEDIC0474.901.211 · report of 18-11-2026

Board, signature and ownership

Position on 18-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts

Who represents the company

Checked did not find the signing rule in the deeds it read.

Board

three directors in office
Directorappointed by deed of 07-04-2014
deed of 07-04-2014
Directorappointed by deed of 09-01-2015
deed of 09-01-2015
Directorrenewed by deed of 30-01-2013
deed of 30-01-2013

Ownership and group

Shareholders

Accounts in the micro format list no shareholders. Checked found none in the deeds or the LEI register either.

Board changes

Registered office moved from Brussels to Laken. The registered office moved from 55 rue gustave demanet à 1020 Bruxelles to drêve Sainte Anne 68 B à 1020 Laken. resigns as director. appointed as director. General meeting of 02-12-2014.

Gazette, deed 15004840

resigns. and reappointed. appointed. General meeting of 24-03-2014.

Gazette, deed 14075273

resigns. , and reappointed. General meeting of 03-01-2013.

Gazette, deed 13017723
INFIMEDIC · 0474.901.211 · credit report of 18-11-2026Page 3 of 5
INFIMEDIC0474.901.211 · report of 18-11-2026

Events and comparison

The last 24 months, newest first

Annual accounts 2025 filed, 17 days before the deadline.

NBB filing

Annual accounts 2024 filed, 13 days before the deadline.

NBB filing

Back to profit. The net result is €19,305, after one loss-making year.

Financial

Liquidity more than doubled. The current ratio rises from 9.67 to 20.34. Short-term debt falls from €3,105 to €2,935.

Financial

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as INFIMEDIC has now: micro, 20 years or older, solvency 30% or more and a profit of 5% of the balance sheet or more. Two years later 93.4% were still trading, 6.1% had stopped another way and 0.5% had gone bankrupt.

still trading 93.4% stopped another way 6.1% bankrupt 0.5%

In 2025, INFIMEDIC had a lower net result than 86% of the 21,324 companies in the human health sector (NACE 86).

Other findings

Peppol

Not listed in the Peppol Directory.

Sanctions lists

Staff

3 employees on 31-12-2025, 1.2 full-time equivalents on average over the year.

INFIMEDIC · 0474.901.211 · credit report of 18-11-2026Page 4 of 5
INFIMEDIC0474.901.211 · report of 18-11-2026

Sources and method

Where each fact in this report comes from

SourceWhatDateReference
KBO registerRegistration, legal situation, activity, establishment units18-11-2026KBO 0474.901.211
National Bank of BelgiumAnnual accounts 2025, micro format14-07-20262026-00291119
National Bank of BelgiumAnnual accounts 2024, micro format18-07-20252025-00288124
National Bank of BelgiumAnnual accounts 2021 to 202329-08-2022 to 29-08-20242022-20411033, 2023-00404975, 2024-00398719
Belgian Official GazetteBoard09-01-2015deed 15004840
Belgian Official GazetteBoard07-04-2014deed 14075273
Belgian Official GazetteBoard30-01-2013deed 13017723
Sanctions lists EU, UN, US (OFAC) and UKComparison of the name16-11-2026no match
CheckedChecked score, bankruptcy probability, credit, comparable companies17-11-2026bankruptcy model of 2 October 2026

Method

Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.

Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 17-11-2026.

Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.

Payment terms. Supplier credit is the debt to suppliers divided by the year's purchases, times 365. Customer credit is the same for what customers still owe, against turnover.

Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.

The scores and ratios are Checked's own calculations, not a credit decision.

INFIMEDIC · 0474.901.211 · credit report of 18-11-2026Page 5 of 5